Open AccessAn open science pathway for drug marketing authorization—Registered drug approval
Author(s) -
Florian Naudet,
Maximilian Siebert,
Rémy Boussageon,
Ioana A. Cristea,
Erick H. Turner
Publication year - 2021
Publication title -
plos medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.847
H-Index - 228
eISSN - 1549-1676
pISSN - 1549-1277
DOI - 10.1371/journal.pmed.1003726
Subject(s) - drug , marketing authorization , medicine , drug approval , authorization , prior authorization , new drug application , pharmacology , business , family medicine , bioinformatics , computer science , computer security , biology
Florian Naudet and co-authors propose a pathway involving registered criteria for evaluation and approval of new drugs.